Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01462708 · ClinicalTrials.gov registry record · Phase 1

Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects

A Phase 1 study of Parkinson Disease, sponsored by Institute for Neurodegenerative Disorders.

Completed
Registry status
Phase 1
Development phase
16
Enrollment target
1
Study location

NCT01462708 is a Phase 1 study of Parkinson Disease that has completed, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 16 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01462708, a Phase 1 study of Parkinson Disease, has completed, sponsored by Institute for Neurodegenerative Disorders.

COMPLETED
Registry status
Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess MK-9470 Positron Emission Tomography (PET) imaging as a tool to evaluate the activity of the CB-1 receptor in the brain.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG [18F]MK-9470

Study Locations (1)

Connecticut

  • Institute for Neurodegenerative Disorders - New Haven

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2011-05
Est. Completion 2013-05
Phase Phase 1

Sponsor

Institute for Neurodegenerative Disorders

37 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01462708

The ClinicalTrials.gov registry entry for NCT01462708 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Institute for Neurodegenerative Disorders, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which [18F]MK-9470 is the first listed.

NCT01462708 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01462708 about?

NCT01462708 is a clinical study titled "Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects". The purpose of this study is to assess MK-9470 Positron Emission Tomography (PET) imaging as a tool to evaluate the activity of the CB-1 receptor in the brain.

What is the current status of trial NCT01462708?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2011-05. Estimated completion is 2013-05.

What conditions does trial NCT01462708 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT01462708?

The interventions under investigation include: [18F]MK-9470 (DRUG).

Who is sponsoring clinical trial NCT01462708?

This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01462708 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.